Vimarsana
Biggest News Aggregation in the World

Page 3 - Aptose Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptose Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptose Bioscience Today - Breaking & Trending Today

Oppenheimer Equities Analysts Raise Earnings Estimates for Aptose Biosciences Inc. (NASDAQ:APTO) - Vimarsana News

Oppenheimer Equities Analysts Raise Earnings Estimates for Aptose Biosciences Inc. (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Oppenheimer upped their FY2025 EPS estimates for Aptose Biosciences in a note issued to investors on Tuesday, August 2nd. Oppenheimer analyst M. Biegler now expects that the biotechnology company will earn $0.33 per share for the year, up from their prior forecast of […]

Aptose Biosciences Inc. (TSE:APS) Forecasted to Post FY2025 Earnings of $0.42 Per Share - Vimarsana News

Aptose Biosciences Inc. (TSE:APS) Forecasted to Post FY2025 Earnings of $0.42 Per Share

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Critical Contrast: Aptose Biosciences (NASDAQ:APTO) & Caribou Biosciences (NASDAQ:CRBU) - Vimarsana News

Critical Contrast: Aptose Biosciences (NASDAQ:APTO) & Caribou Biosciences (NASDAQ:CRBU)

Aptose Biosciences (NASDAQ:APTO – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Institutional and Insider Ownership 34.2% of Aptose Biosciences shares […]

Analysts Offer Predictions for Aptose Biosciences Inc.'s Q1 2023 Earnings (NASDAQ:APTO) - Vimarsana News

Analysts Offer Predictions for Aptose Biosciences Inc.'s Q1 2023 Earnings (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Piper Sandler issued their Q1 2023 earnings estimates for shares of Aptose Biosciences in a report released on Tuesday, March 22nd. Piper Sandler analyst E. Tenthoff anticipates that the biotechnology company will earn ($0.16) per share for the quarter. Piper Sandler also issued […]

Aptose Biosciences Inc. Forecasted to Earn Q1 2022 Earnings of ($0.13) Per Share (NASDAQ:APTO) - Vimarsana News

Aptose Biosciences Inc. Forecasted to Earn Q1 2022 Earnings of ($0.13) Per Share (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Stock analysts at Oppenheimer issued their Q1 2022 earnings estimates for shares of Aptose Biosciences in a research note issued to investors on Wednesday, March 23rd. Oppenheimer analyst M. Biegler expects that the biotechnology company will post earnings per share of ($0.13) for the quarter. Oppenheimer […]